HIV Medication Information Sheets

The medication information sheets listed below are intended to provide a general overview of the antiretroviral drugs available through the BC-CfE’s Drug Treatment Program.  They do not cover specific information for individualized medical conditions (e.g. pregnancy, renal or liver disease) or replace sound medical judgment.

Healthcare providers should refer to the BC-CfE’s Therapeutic Guidelines for more specific information on monitoring patients who are taking antiretroviral therapy.  HIV therapy is a complicated, ever-changing topic, and providers are encouraged to make treatment decisions in consultation with qualified experts in HIV treatment.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below